PET/CT shows underlying metabolic and functional changes in the brain attributable to traumatic brain injury (as in auto-accidents), Alzheimer’s disease and other neurodegenerative disorders.
Often, these findings are seen before the onset of typical symptoms, and can be a fundamental cause of developing neuropsychiatric disturbances.
Correct diagnosis can help to maintain a patient’s quality of life by determining the correct therapy for the correct disorder. Disease-specific patterns allow correct classification in 95% of patients with Alzheimer disease, 92% of patients with DLB, 94% of patients with FTD, and 94% of healthy subjects.1,2
With a correct imaging diagnosis, families can more easily facilitate insurance and legal approval for both medication, rehab, and in the worst-case, hospice management.
Competitive outpatient rates, Medicare and most insurances accepted.**
To schedule a PET-CT or PET-MRI Brain study, please contact Excel Medical Imaging by calling or booking your appointment online.
1Brown et al. Brain PET in Suspected Dementia: Patterns of Altered FDG Metabolism. Radiographics. Volume 34, Issue 3. May-June 2014.
2Mosconi L, Tsui WH, Herholz K, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias. J Nucl Med 2008;49(3):390–398.
**Note: Amyvid dosing provided only with self-pay compensation for drug costs.